Moreover, it has been reported that CD56 acts as an independent prognostic factor in ALCL, and the expression of CD56 in ALCL is suggestive of a poorer overall prognosis in both the ALK-positive and ALK-negative subgroups (22). The gene discussed is NCAM1; the disease is anaplastic large cell lymphoma.